XML 55 R28.htm IDEA: XBRL DOCUMENT v3.25.2
Summary of Significant Accounting Policies Summary of Significant Accounting Principles (Tables)
 12 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Schedule of Other Nonoperating Income (Expense)
Other (Expense) Income, Net
The following table summarizes the components of other (expense) income, net.
 Year Ended June 30,
202520242023
(Losses) gains on derivatives not designated as hedging instruments (1)$(35,027)$3,915 $3,311 
Currency-related gains (losses), net (2)21,090 (2,818)16,350 
Other gains (losses)355 486 (1,163)
Total other (expense) income, net
$(13,582)$1,583 $18,498 
_____________________
(1) Includes realized and unrealized gains and losses on derivative currency forward and option contracts not designated as hedging instruments, as well as the ineffective portion of certain interest rate swap contracts that have been de-designated from hedge accounting. For contracts not designated as hedging instruments, we realized gains (losses) of $2,706, $(1,078) and $39,133, respectively, for the fiscal years ended June 30, 2025, 2024 and 2023. Refer to Note 4 for additional details relating to our derivative contracts.
(2) Currency-related gains (losses), net primarily relates to significant non-functional currency intercompany financing relationships that we may change at times and are subject to currency exchange rate volatility. In addition, during all fiscal years presented, we had certain cross-currency swaps designated as cash flow hedges, which hedge the remeasurement of certain intercompany loans; refer to Note 4 for additional details relating to these cash flow hedges.
Schedule of Weighted Average Number of Shares
The following table sets forth the reconciliation of the weighted-average number of ordinary shares.
 Year Ended June 30,
 202520242023
Weighted average shares outstanding, basic24,923,797 26,151,968 26,252,860 
Weighted average shares issuable upon exercise/vesting of outstanding share options/RSUs/PSUs/warrants (1)
713,068 852,719 — 
Shares used in computing diluted net income (loss) per share attributable to Cimpress plc25,636,865 27,004,687 26,252,860 
Weighted average anti-dilutive shares excluded from diluted net income (loss) per share attributable to Cimpress plc (1)(2)1,001,612 96,207 2,834,351 
___________________
(1) In the periods in which a net loss is recognized, the impact of share options, PSUs, RSUs and warrants is excluded from shares used in computed diluted net income (loss) per share as it is anti-dilutive. Any equity awards that have a performance condition are not included in dilutive or anti-dilutive shares until the performance condition would have been met as of the end of the reporting period.
(2) On May 1, 2020, we entered into a financing arrangement, which included 7-year warrants to purchase 1,055,377 of our ordinary shares with a strike price of $60 that have a potentially dilutive impact on our weighted average shares outstanding. For the years ended June 30, 2025 and 2024, the average market price of our ordinary shares was higher than the strike price of the warrants; therefore, the weighted average dilutive effect of the warrants were 147,329 and 220,668, respectively. For the year ended June 30, 2023, the average share price was below the strike price for the full fiscal year; therefore, the total 1,055,377 outstanding warrants were considered anti-dilutive.